Blue Horseshoe Stocks

Blue Horseshoe Stocks: NBEV Recap & More

New Age Beverages Corp. NBEV

It was back on the 9th of this month that we selected NBEV as a potential bottom play, and wanted to kick off the week by swinging back around to recap the excellent move the stock has made for us thus far.

After seeing a low of 2.11 on the morning of our initial alert, the stock has continually risen over the eight sessions since, touching a high of 4.24 on Friday. That represents a very nice 101% move, while volume over the same period has been notably increased. We’ll continue to monitor the progress here in coming sessions.

PetMed Express Inc. PETS

Speaking of steady risers, we’ve watched PETS for quite awhile now, having mentioned it for the first time in our report from the morning of September 11th.

Subsequent to that report, we observed a low of 32.90 and despite already being a thirty dollar stock, we’ve still seen it increase gradually and significantly, culminating at Friday’s high of 53.89. That marks a 64% increase, which is absolutely fantastic for a stock in this price range.

We’ll be interested to see how the stock is affected by the company’s solid premarket earnings release today. It’s gapping up in early trading and it appears we will see our observed highs boosted yet again.

Extended Watchlist:
ATEN, ARRY, LTBR, NINE, LFIN, ACST

Blue Horseshoe Stocks: XXII Update & More

22nd Century Group, Inc. XXII

It was back on November 7th that we highlighted a large group of cannabis stocks, and professed our unyielding interest in the space as a whole. XXII was among those that we specifically highlighted as promising pot stocks in that report, and despite it being more than 8 weeks later, the stock has continually bulled its ways to new highs ever since.

We wanted to swing back around this morning to outline the excellent run it has been on since November. Subsequent to our report on the 7th the stock saw an absolute bottom of 2.00 even before beginning its months-long ascent. Yesterday the stock reached yet another new high of 3.85, marking an overall upswing of 93%

Yield10 Bioscience, Inc. YTEN

Following a huge single session run in early December, YTEN was unable to hold onto any of the ground it had gained, and with the ‘help’ of a massive public offering, continued to descend until recently.

This week, the stock has begun to show signs of a bottom bounce, and we’re going to want to add it to the radar on a recovery watch. As you can see form the chart snapshot included below, there is a lot of room for a potential surge, including a gap to fill to the upside.

Extended Watchlist:
NVAX, RKDA, SDRL, CRBP, SQ, CHFS, NBEV, SIEN, CNET

Blue Horseshoe Stocks: Fresh Options Ideas & More

SPDR S&P 500 ETF (SPY) – Options Recap

Yesterday we offered up our opinion that the SPY was going to get back to its bullish ways, and outlined what we felt was an attractive set of contracts in the options chain, the SPY 01/17 $277.50-279 Calls. It was for quick-strike trades only, given that they expired at 4 o’clock, and the chances were certainly there for the taking.

We said we’d be looking for the classic dip and rip pattern to present those chances for intraday flips, and our idea couldn’t have worked out much better, including our second instance of multiple thousand percent gainers in the past week! The potential single session profits on the table were as follows:

$277.50 Calls – Range: .41-2.53 – Max Gain: 517%
$278 Calls – Range: .21 -2.03 – Max Gain: 867%
$278.50 Calls – Range: .10-1.54 – Max Gain: 1440%
$279 Calls – Range: .05-1.04 – Max Gain: 1980%

The York Water Co. YORW

We also want to submit a fresh options idea this morning to coincide with an ideal chart setup on YORW. As you can see on the included snapshot, the stock began to rebound off of a multiple-bottom setup and looks as if it could easily make a run of at least a few dollars in a potential recovery.

We’ll be ready with a couple of contracts to track in the event that a more sustained upswing is in the cards, with the YORW 02/16 $30 & $35 Calls.

Extended Watchlist:
AES, CNET, RIOT, LFIN, OAKS, NBEV, MARA,

Blue Horseshoe Stocks: Cannabis News Play & More

Stereo Vision Entertainment SVSN

We had SVSN hit our scanner this morning after we noticed an interesting PR coming across the wires. We’re always looking for new interests in the cannabis space, and SVSN fits that bill. Unlike many of the companies in the business conduct their activities primarily in the western states, SVSN has an operation in Florida.

The company just announced a February 1, 2018 Grand Opening of its majority owned subsidiary CannaVision’s Bay Pines medical cannabis and holistic pain management clinic in St Petersburg, Florida. (>>View PR)

We’ll be interested to track the progress of this new facility, and SVSN stock itself going forward.

SPDR S&P 500 ETF (SPY)

We also want to throw in a quick options idea for the SPY, which despite a momentary hiccup in its week’s-long bullish trend yesterday, looks to be gapping up and ready to get back on track today. There are a set of contracts expiring today that we want to radar: the SPY 01/17 $277.50-279 Calls*.

Please be aware that contracts approaching expiration are subject to evaporating premiums due to time decay, so these are quick-strike opportunities only. We’ll be looking for the classic early dip and rip pattern, which should present those chances for intraday flips.

*Be aware that this idea is extremely high risk, and for advanced level traders only!

Extended Watchlist:
TVPC, DDD, MITK, ADAP, ARGS, IOVA

Blue Horseshoe Stocks: DAL, GALT Updates & More

Delta Air Lines, Inc. DAL – Options Recap

We followed a range of Delta options beginning on Thursday morning, when we signaled the DAL Weekly $57-58 Calls in the wake of the company’s across-the-board Q4 earnings beat. We were glad to report on Friday that in a single session those three sets of contracts yielded gains ranging from roughly 780% to 1980%

Despite making such big moves already, Friday’s session brought more success for our tracked calls, so we wanted to open up this short trading week with a final recap on the maximum gains allowed by those excellent weekly contracts. The total ranges we observed over just two sessions were amazing.

$57 Calls – Range: .24-3.44 – Max Gain: 1313%
$57.50 Calls – Range: .14-2.96 – Max Gain: 2014%
$58 Calls – Range: .06-2.40 – Max Gain: 3900%

Galectin Therapeutics, Inc. GALT

We also want to swing back around for GALT, a stock we routinely tracked throughout 2017. It finished off that yea with a bang, and has continued its excellent run into 2018.

From lows it saw at the beginning of December at 1.28, to the new highs it made at the end of last week at 6.15 , GALT had executed a 380% increase in roughly five weeks!

Extended Watchlist:
NCTY, HEB, BB, OSIS, OTIV, HAWK